ProCE Banner Activity

Navigating the Gray Zone: Importance of Monitoring Patients With Indeterminate-Phase CHB

Clinical Thought

Patients with indeterminate-phase—or “gray zone”—chronic hepatitis B may not meet the criteria for antiviral therapy but are still at risk for disease progression. Learn how I navigate their care.

Released: December 21, 2023

Share

Faculty

Maria Buti

Maria Buti, MD

Professor of Medicine
Senior Consultant
Liver Unit
Hospital Universitario Valle Hebron
Barcelona, Spain

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Disclosure

Primary Author

Maria Buti, MD

Professor of Medicine
Senior Consultant
Liver Unit
Hospital Universitario Valle Hebron
Barcelona, Spain

Maria Buti, MD: consultant/advisor/speaker: AbbVie, Gilead, GlaxoSmithKline, Janssen.